Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

US Patent 8354545 · Granted Jan 15, 2013

Estimated economic value: $88,184,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Pyrrolidine orexin receptor agonists2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
GLS1 inhibitors for treating disease2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2021
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2021
Heterocyclic modulators of HIF activity for treatment of disease2021
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists2021
Piperidine derivatives as liver X receptor beta agonists, compositions, and thei2021
GLS1 inhibitors for treating disease2020